Allston, MA · Founded 2020 · Privately Held (backing)
Developer of oncological drugs designed to treat RAS-driven cancers and bring a new therapy to cancer's frequently mutated oncogenic target. Kestrel Therapeutics is based in Allston, MA and was founded in 2020. Its last reported valuation was $17.7 million in Jan 2022. It has raised $20.7 million across 3 recorded rounds; the latest was a $5 million early-stage round in Jul 2025.
Last reported valuation
$17.7M
Oct 2026
Priced at
—
Total raised
$20.7M
Last round
Early Stage VC
Jul 2025
Cap table — not yet on record
Kestrel Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Kestrel Therapeutics with a free account
·Watch Kestrel Therapeutics: the Monday email on marks, rounds and moves
Where does Kestrel Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Kestrel Therapeutics's 3 recorded funding rounds.
